Phase 1 Study of KHK2898 in Subjects With Advanced Solid Tumors

NCT01516645 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

14

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumour

Interventions

DRUG: KHK2898

Sponsor

Kyowa Kirin Co., Ltd.